Literature DB >> 23017146

NIR-responsive and lectin-binding doxorubicin-loaded nanomedicine from Janus-type dendritic PAMAM amphiphiles.

Lin Sun1, Xiaofei Ma, Chang-Ming Dong, Bangshang Zhu, Xinyuan Zhu.   

Abstract

Janus-type dendritic poly(amido amine) (PAMAM) amphiphiles Dm-Lac-D3DNQ were synthesized by connecting hydrophobic diazonaphthoquinone (DNQ)-decorated PAMAM dendron D3 (generation 3) and hydrophilic lactose (Lac)-decorated PAMAM dendrons Dm (generations 0-2, m = 0-2) via click chemistry. They self-assembled into the DNQ-cored micelles dangled by densely free Lac groups in aqueous solution. Irradiated by 808 nm laser and 365 nm lamp, both NIR- and UV-sensitivity of micelles were characterized by time-resolved UV-vis spectroscopy. The characteristic absorption intensity of DNQ progressively decreased and then leveled off. Moreover, the bigger the micelles, the more the irradiation time for finishing Wolff rearrangement of DNQ. TEM further confirmed that most of the micelles disassembled after 30 min of 808 nm laser irradiation. The Lac-coated micelles showed binding with RCA(120) lectin, as monitored by UV-vis and DLS. The apparent drug-release rate of doxorubicin (DOX) loaded nanomedicine nearly doubled after 10 min of 808 nm laser irradiation, presenting a NIR-triggered drug-release profile. Moreover, the DOX-loaded nanomedicine presented a phototriggered cytotoxicity that was close to free DOX, and they could quickly enter into HeLa cells, as evidenced by MTT assay, flow cytometry, and CLSM. Importantly, this work provides a versatile strategy for the fabrication of NIR-responsive and lectin-binding dendrimer nanomedicine, opening a new avenue for "on-demand" and spatiotemporal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017146     DOI: 10.1021/bm3010325

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

1.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

2.  Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy.

Authors:  Manju Saraswathy; Gavin T Knight; Srikanth Pilla; Randolph S Ashton; Shaoqin Gong
Journal:  Colloids Surf B Biointerfaces       Date:  2015-01-03       Impact factor: 5.268

3.  Materials innovation for co-delivery of diverse therapeutic cargos.

Authors:  Megan E Godsey; Smruthi Suryaprakash; Kam W Leong
Journal:  RSC Adv       Date:  2013-12-21       Impact factor: 3.361

4.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

5.  NIR-/pH-Responsive drug delivery of functionalized single-walled carbon nanotubes for potential application in cancer chemo-photothermal therapy.

Authors:  Lei Wang; Jinjin Shi; Xin Jia; Ruiyuan Liu; Honghong Wang; Zhenzhen Wang; Lulu Li; Jing Zhang; Chaofeng Zhang; Zhenzhong Zhang
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

6.  Photoresponsive nanoparticles for drug delivery.

Authors:  Alina Y Rwei; Weiping Wang; Daniel S Kohane
Journal:  Nano Today       Date:  2015-07-15       Impact factor: 20.722

Review 7.  The potential of polymeric micelles in the context of glioblastoma therapy.

Authors:  Ramin A Morshed; Yu Cheng; Brenda Auffinger; Michelle L Wegscheid; Maciej S Lesniak
Journal:  Front Pharmacol       Date:  2013-12-30       Impact factor: 5.810

8.  Janus second-order nonlinear optical dendrimers: their controllable molecular topology and corresponding largely enhanced performance.

Authors:  Runli Tang; Shengmin Zhou; Ziyao Cheng; Gui Yu; Qian Peng; Huiyi Zeng; Guocong Guo; Qianqian Li; Zhen Li
Journal:  Chem Sci       Date:  2016-08-17       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.